prism 4.0 software for windows 10 Search Results


90
Elicityl Inc hmo11
Hmo11, supplied by Elicityl Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/10__1039_slash_c7an01397c-83-97-61?v=Elicityl+Inc
Average 90 stars, based on 1 article reviews
hmo11 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Corning Life Sciences fitc-9mer nrf2 peptide amide
Fitc 9mer Nrf2 Peptide Amide, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/pmc03309107-122-18-26?v=Corning+Life+Sciences
Average 90 stars, based on 1 article reviews
fitc-9mer nrf2 peptide amide - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Ayerst Laboratories caltrate 600 + d
Caltrate 600 + D, supplied by Ayerst Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/pmc03108160-73-7-25?v=Ayerst+Laboratories
Average 90 stars, based on 1 article reviews
caltrate 600 + d - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Custom Monoclonals International horse igm
Horse Igm, supplied by Custom Monoclonals International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/us08563249-2703-24-28?v=Custom+Monoclonals+International
Average 90 stars, based on 1 article reviews
horse igm - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Avantor 0.1 μm gelman acrodisk syringe filter
0.1 μm Gelman Acrodisk Syringe Filter, supplied by Avantor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/us07923426-96-17-21?v=Avantor
Average 90 stars, based on 1 article reviews
0.1 μm gelman acrodisk syringe filter - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
BIOTAGE biotage isolera
Biotage Isolera, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/us10420777-1602-19-21?v=BIOTAGE
Average 90 stars, based on 1 article reviews
biotage isolera - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

95
Zymo Research dna
Dna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/pm34786730-542-3-10?v=Zymo+Research
Average 95 stars, based on 1 article reviews
dna - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

94
Tymora Analytical Operations LLC pimago western blot kit
(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. <t>PIMAGO</t> western blot kit was used to detect <t>phospho-GST-Cdh1.</t> <t>Phosphorylation</t> was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .
Pimago Western Blot Kit, supplied by Tymora Analytical Operations LLC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/bio_rxiv__535799-187-6-9?v=Tymora+Analytical+Operations+LLC
Average 94 stars, based on 1 article reviews
pimago western blot kit - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

90
Enzo Biochem flash column chromatography 3/5
(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. <t>PIMAGO</t> western blot kit was used to detect <t>phospho-GST-Cdh1.</t> <t>Phosphorylation</t> was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .
Flash Column Chromatography 3/5, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/pmc11168096__SC___015___D4SC01410C___s001-2934-8-12?v=Enzo+Biochem
Average 90 stars, based on 1 article reviews
flash column chromatography 3/5 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

94
Boston BioProducts bis tris gels
(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. <t>PIMAGO</t> western blot kit was used to detect <t>phospho-GST-Cdh1.</t> <t>Phosphorylation</t> was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .
Bis Tris Gels, supplied by Boston BioProducts, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/10__1074_slash_jbc__m116__747816-304-8-27?v=Boston+BioProducts
Average 94 stars, based on 1 article reviews
bis tris gels - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

86
Merck & Co merck cartridge
(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. <t>PIMAGO</t> western blot kit was used to detect <t>phospho-GST-Cdh1.</t> <t>Phosphorylation</t> was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .
Merck Cartridge, supplied by Merck & Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/us12583861-772-10-10?v=Merck+%26+Co
Average 86 stars, based on 1 article reviews
merck cartridge - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
Zymo Research zymogen dna elution buffer
(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. <t>PIMAGO</t> western blot kit was used to detect <t>phospho-GST-Cdh1.</t> <t>Phosphorylation</t> was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .
Zymogen Dna Elution Buffer, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+4%2E0+software+for+windows+10/10__22175_slash_mmb__16086-86-9-13?v=Zymo+Research
Average 95 stars, based on 1 article reviews
zymogen dna elution buffer - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

Image Search Results


(A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. PIMAGO western blot kit was used to detect phospho-GST-Cdh1. Phosphorylation was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .

Journal: bioRxiv

Article Title: Chk1 Phosphorylates Cdh1 to Promote SCF βTRCP -Dependent Degradation of Cdh1 During S-Phase

doi: 10.1101/535799

Figure Lengend Snippet: (A) Chk1 phosphorylates Cdh1 in-vitro . GST-Cdh1 was phosphorylated with Chk1 through In-vitro kinase assays. Immunoblot represents immunoprecipitated GST-Cdh1 on glutathione beads following in-vitro kinase assays. PIMAGO western blot kit was used to detect phospho-GST-Cdh1. Phosphorylation was further confirmed by including Chk1 inhibitor where indicated during the kinase assays or by treating phosphorylated GST-Cdh1 with phosphatase. (B) Schematic diagram of Cdh1. Chk1-mediated phosphorylation sites identified from mass-spectrometry analysis are indicated in blue. Cdh1 phosphorylation sites mediated by Cyclin A-Cdk2 and Plk1 are in red and magenta, respectively. The SCF-βTRCP1 phosphodegron is indicated. (C). Chk1 mediated phosphorylation of Cdh1 creates a binding site for βTRCP1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1. Cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr and the interaction between HA-Cdh1 and Flag-βTRCP1 was analyzed. Immunoprecipiated HA - Cdh1 WT and the mutant band intensities were first normalized to their relative amounts in lysates. The relative amount of the indicated Cdh1 proteins bound to Flag-βTRCP1 was normalized to wild type HA-Cdh1. See also Figure EV2A . (D) Cdh1 interacts with Chk1 in vivo. Both HA-Cdh1 and constitutively active Myc-Chk1 L449R were co-expressed in 293T cells. 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. The interaction between HA-Cdh1 and Myc-Chk1 L449R proteins was monitored by immunoprecipitation. (E) Constitutively active Chk1 promotes Cdh1 and SCF βTRCP1 interaction in-vivo . Immunoblot analysis of immunoprecipitates and whole-cell lysates derived from 293T cells transfected with Flag-βTRCP1, HA-Cdh1 and Myc-Chk1 L449R (where indicated). 30 hr post-transfection, cells were treated with proteasome inhibitor MG132 (10 µM) for 5 hr. Immunoprecipiated HA - Cdh1 band intensities (EV2B) were normalized to their respected Flag-βTRCP1 IP bands and then further normalized to control. (F) n-vivo ubiquitination assays shows that SCF βTRCP1 promotes Cdh1 ubiquitination in a Chk1 dependent manner. (G) Mutations of Chk1 mediated phosphorylation sites in Cdh1 increases the stability of Cdh1. 293T cells were transfected with the indicated HA-Cdh1 constructs together with Flag-βTRCP1 and Myc-Chk1 L449R (where indicated). Cells were treated with 50 µg/ml cycloheximide (CHX). At the indicated time points, whole-cell lysates were prepared for immunoblot analysis. The intensities of Cdh1 bands were normalized to actin, then normalized to the t=0 time point. The plots represent the relative fraction of indicated Cdh1 protein at final time point (t=320 min) after adding CHX. Data are represented as mean +/- SD, n=3 biological replicates. See also (EV2C) .

Article Snippet: Phosphorylation of GST-Cdh1 was detected by pIMAGO western-blot kit (Tymora Chemicals).

Techniques: In Vitro, Western Blot, Immunoprecipitation, Mass Spectrometry, Binding Assay, Transfection, Construct, Mutagenesis, In Vivo, Derivative Assay